Italy

CENTRO AVANZATO DI DIAGNOSTICA 'Alessandro Bertinaria'

Regione Gonzole 10/1, 10043, Orbassano, Italy

ACCREDIA 00731ISO/IEC 17025Register refreshed 2026-11-06

We check which accredited labs can do it, starting with this one, and send you a short comparison of time and rough cost within three working days.

Free. No lab gets your details until you choose.

Scope lines: 2
ACCREDIA certificate: 1
Site in our directory: 1

ACCREDIA accredited scope

What this lab is accredited for

We found no published test standard numbers in this lab’s scope. The full scope as published is below.

Search this lab’s scope for a standard or test

Only this lab. Searches the method, matrix and range of each of the 2 scope lines.

ACCREDIA certificate 00731 · 2 lines

Line	Method	Matrix	Range
1	-	Campioni biologici/Biological samples; Reperti/Exhibits; Matrice cheratinica umana/Human keratin matrix; Sangue intero umano/Human whole blood; Siero di sangue umano/Human blood serum; Urina umana/Human urine Show page text Extracted from the scope document; tables may not line up. View scope for the original. Allegato al certificato di accreditamento n. 00731 rev. 8 del 03/02/2026 CENTRO AVANZATO DI DIAGNOSTICA "Alessandro Bertinaria" Regione Gonzole 10/1 10043 Orbassano TO UNI CEI EN ISO/IEC 17025:2018 Revisione: 44 Sede A Data: 03/02/2026 pag. 1 di 2 ELENCO Prove Accreditate - Con Campo Fisso in Categoria: 0 Campioni biologici/Biological samples, Reperti/Exhibits Denominazione della prova / Campi di prova Metodo di prova Tecnica di prova O&I Polimorfismi genetici del DNA/DNA polymorphism genetics, Tipizzazione DNA umano/Human DNA typing (65-500 bp) PSBF001 Rev14 2025 Elettroforesi capillare Matrice cheratinica umana/Human keratin matrix Denominazione della prova / Campi di prova Metodo di prova Tecnica di prova O&I PSCH034 Rev14 2024 UHPLC-MS/MS PSCH055 Rev4 2024 UHPLC-MS/MS PSCH043 Rev7 2025 UHPLC-MS/MS 11-nor-9-carbossi- Delta-9-tetraidrocannabinolo (THC-COOH)/11-nor-9-carboxy Delta-9-Tetrahydrocannabinol (THC-COOH), Delta-9-Tetraidrocannabinolo (THC)/Delta-9-Tetrahydrocannabinol (THC) (> 20 pg/mg per THC, > 0.2 pg/mg per THC-COOH) 2-etilden-1,5dimetil-difenilpirrolidina (EDDP)/2-ethylidene-1,5dimethyl-diphenylpyrrolidine (EDDP), 3-4-Metilendiossiamfetamina (MDA)/3-4-Methylenedioxyamphetamine (MDA), 3-4-Metilendiossietilamfetamina (MDEA)/3-4-Methylenedioxyethylamphetamine (MDEA), 3-4-Metilendiossimetamfetamina (MDMA o ECSTASY)/3-4-Methylenedioxymethamphetamine (MDMA o ECSTASY), 6-monoacetilmorfina (6-MAM)/6-monoacetylmorphine (6-MAM), Benzoilecgonina (BZE)/Benzoylecgonine (BZE), Buprenorfina/Buprenorphine, Cocaetilene/Cocaethylene, Cocaina/Cocaine, Codeina/Codeine, Ketamina/Ketamine, Metadone/Methadone, Morfina/Morphine, Norbuprenorfina/Norbuprenorphine, Norketamina/Norketamine (> 0.1 ng /mg, > 0.01 ng /mg per Buprenorfina e Nor-Buprenorfina, > 0.05 ng /mg per BZE e Cocaetilene) 3-4-Metilendiossiamfetamina (MDA)/3-4-Methylenedioxyamphetamine (MDA), 3-4-Metilendiossietilamfetamina (MDEA)/3-4-Methylenedioxyethylamphetamine (MDEA), 3-4-Metilendiossimetamfetamina (MDMA o ECSTASY)/3-4-Methylenedioxymethamphetamine (MDMA o ECSTASY), 6-monoacetilmorfina (6-MAM)/6-monoacetylmorphine (6-MAM), Amfetamina/Amphetamine, Benzoilecgonina (BZE)/Benzoylecgonine (BZE), Buprenorfina/Buprenorphine, Cocaetilene/Cocaethylene, Cocaina/Cocaine, Codeina/Codeine, Delta-9-Tetraidrocannabinolo (THC)/Delta-9-Tetrahydrocannabinol (THC), Ketamina/Ketamine, Metadone/Methadone, Metamfetamina (MAMP)/Methamphetamine (MAMP), Morfina/Morphine (> 0.1 ng /mg /; > 0.01 ng /mg per Buprenorfina; > 0.025 ng /mg per Ketamina, BZE e THC) Etilglucuronato (ETG)/Ethylglucuronide (> 10 pg /mg /) PSCH037 Rev12 2024 UHPLC-MS/MS Metodo di prova Tecnica di prova O&I PSCH045 Rev8 2024 UHPLC-MS/MS Sangue intero umano/Human whole blood Denominazione della prova / Campi di prova 11-idrossi-Delta 9-tetraidrocannabinolo (THC-MET)/11-hydroxy-Delta-9-Tetrahydrocannabinol (THC-MET), 3-4-Metilendiossiamfetamina (MDA)/3-4-Methylenedioxyamphetamine (MDA), 3-4-Metilendiossimetamfetamina (MDMA o ECSTASY)/3-4-Methylenedioxymethamphetamine (MDMA o ECSTASY), 6-monoacetilmorfina (6-MAM)/6-monoacetylmorphine (6-MAM), Amfetamina/Amphetamine, Buprenorfina/Buprenorphine, Cocaetilene/Cocaethylene, Cocaina/Cocaine, Codeina/Codeine, Delta-9-Tetraidrocannabinolo (THC)/Delta-9-Tetrahydrocannabinol (THC), Ketamina/Ketamine, Metadone/Methadone, Metamfetamina (MAMP)/Methamphetamine (MAMP), Morfina/Morphine (> 5ng/mL per Cocaina, 6-MAM, Morfina, Metadone, Codeina, Cocaetilene e Ketamina, > 10 ng/mL per Amfetamina, MDA, MAMP, MDMA, > 1 ng/mL per Buprenorfina, THC e THC-MET) Etanolo (Alcol etilico)/Ethanol (Ethyl alcohol) ( > 0,10 g/L ) PSCH039 Rev8 2024 GC-MS Siero di sangue umano/Human blood serum Denominazione della prova / Campi di prova Transferrina carboidrato carente (CDT) /Carbohydrate-Deficient Transferrin (>0.6%) Urina umana/Human urine Metodo di prova Tecnica di prova O&I PSCC006 Rev13 2024 HPLC-UV-vis Denominazione della prova / Campi di prova Metodo di prova Tecnica di prova O&I 11-nor-9-carbossi- Delta-9-tetraidrocannabinolo (THC-COOH)/11-nor-9-carboxy Delta-9-Tetrahydrocannabinol (THC-COOH) (> 10 ng/mL) PSCH009 Rev12 2024 UHPLC-MS/MS	to 500 bp
2	Extracted from the scope document; tables may not line up. View scope for the original. Allegato al certificato di accreditamento n. 00731 rev. 8 del 03/02/2026 CENTRO AVANZATO DI DIAGNOSTICA "Alessandro Bertinaria" Regione Gonzole 10/1 10043 Orbassano TO UNI CEI EN ISO/IEC 17025:2018 Revisione: 44 Sede A Data: 03/02/2026 pag. 2 di 2 2-etilden-1,5dimetil-difenilpirrolidina (EDDP)/2-ethylidene-1,5dimethyl-diphenylpyrrolidine (EDDP), Metadone/Methadone (> 100 ng/ mL) 2-idrossietilflurazepam/2-hydroxyethylflurazepam, 7-aminoclonazepam/7-aminoclonazepam, 7-aminoflunitrazepam/7-aminoflunitrazepam, 7-aminonitrazepam/7-aminonitrazepam, Alfa-idrossialprazolam/Alpha-hydroxyalprazolam, Alfa-idrossimidazolam/Alpha-hydroxymidazolam, Alfa-idrossitriazolam/Alfa-idrossitriazolam, Alprazolam/Alprazolam, Bromazepam/Bromazepam, Clonazepam/Clonazepam, Delorazepam/Delorazepam, Demoxepam/Demoxepam, Desalchilflurazepam/Desalkylflurazepam, Diazepam/Diazepam, Fenobarbital/Phenobarbital, Flunitrazepam/Flunitrazepam, Lorazepam/Lorazepam, Lormetazepam/Lormetazepam, Midazolam/Midazolam, Nordiazepam/Nordiazepam, Oxazepam/Oxazepam, Prazepam/Prazepam, Secobarbital/Secobarbital, Temazepam/Temazepam, Triazolam/Triazolam, Zolpidem/Zolpidem, Zopiclone/Zopiclone (> 50 ng/mL) 3-4-Metilendiossiamfetamina (MDA)/3-4-Methylenedioxyamphetamine (MDA), 3-4-Metilendiossimetamfetamina (MDMA o ECSTASY)/3-4-Methylenedioxymethamphetamine (MDMA o ECSTASY), Amfetamina/Amphetamine, Ketamina/Ketamine, Metamfetamina (MAMP)/Methamphetamine (MAMP), Norketamina/Norketamine (> 100 ng/mL) 6-monoacetilmorfina (6-MAM)/6-monoacetylmorphine (6-MAM), Codeina/Codeine, Morfina/Morphine, Ossicodone/Oxycodone, Ossimorfone/Oxymorphone (> 50 ng/mL Morfina, Codeina, Ossimorfone, Ossicodone; > 5 ng/mL 6-Monoacetilmorfina (6-MAM)) PSCH033 Rev9 2024 GC-MS PSCH032 Rev11 2025 UHPLC-MS/MS PSCH056 rev4 2024 UHPLC-MS/MS PSCH013 Rev13 2024 UHPLC-MS/MS Benzoilecgonina (BZE)/Benzoylecgonine (BZE), Cocaetilene/Cocaethylene (> 50 ng/mL) PSCH024 Rev13 2024 GC-MS Buprenorfina/Buprenorphine, Norbuprenorfina/Norbuprenorphine (> 5 ng /mL) PSCH054 Rev5 2024 UHPLC-MS/MS Legenda/Note Il simbolo (1), se presente, indica: "Materiale/Prodotto/Matrice" non previsto dal metodo ma assimilabile/The symbol (1), if present, means: Material/Product/Matrix not provided for by the method but acceptable Per la definizione della “categoria" di prova indicata nel titolo, si veda il Regolamento Generale ACCREDIA RG-02/For the definition of the test “category” indicated in the title, see ACCREDIA General Regulation RG-02. Il QRcode consente di accedere direttamente al sito www.accredia.it per verificare la validità dell'elenco prove e del certificato di accreditamento rilasciato al laboratorio/The QRcode allows to directly access to the website www.accredia.it to verify the validity of the test list and of the accreditation certificate issued to the laboratory. L’eventuale simbolo “X” riportato nella colonna “O&I” indica che il laboratorio è accreditato anche per fornire opinioni e interpretazioni basate sui risultati delle specifiche prove contrassegnate/Any "X" symbol in the "O&I" column indicates that the laboratory is also accredited to provide opinions and interpretations based on the results of the specific marked tests. L'eventuale simbolo () indica che è attiva una sospensione dell’accreditamento per la specifica attività riportata a fianco/Any symbol () indicates that a suspension of accreditation is active for the specific activity shown next to it.

Ranges are reproduced from the accredited scope document as published, and only where we found that range printed in the document for the line. Otherwise the cell reads “See scope document”. An absent range means the register did not state one. Line numbers are ours, for cross-reference; they follow the order of the scope document.

Location

Regione Gonzole 10/1, Orbassano, 10043, IT

45.03031, 7.55868

Open in Maps

← All accredited testing labs in Italy

Accreditation data refreshed from the ACCREDIA register on 2026-11-06.

This page mirrors a public register. For a purchasing, audit or regulatory decision, confirm against the ACCREDIA entry linked above.